2010
The Center for Genetic Engineering and Biotechnology organizes and celebrates the first edition of the International Congress Controlling diabetes and its most severe complications, which focused its attention on the use of the Cuban drug Heberprot-P®, a leading product of Cuban biotechnology , the only therapy in the world for the effective healing of neuropathic and ischemic diabetic foot ulcers, which reduces the relative risk of lower limb amputation. It is an injectable formulation, designed for an unmet medical need.